Qyuns Therapeutics Funding: $66M Raised, Series C (2021)

Qyuns Therapeutics is based in Taizhou, China. It has raised $66M in total funding. Latest round: Series C.

Qyuns Therapeutics funding overview

Qyuns Therapeutics is based in Taizhou, China. Qyuns Therapeutics has raised $66M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in April 2021. The round record for Qyuns Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Matrix Partners China, Shenzhen Ruixiangyuan Fund Management. 2 distinct backers are named across the disclosed rounds.

Qyuns Therapeutics at a glance

Total raised
$66M
Latest round
Series C
Latest round date
April 2021
Headquarters
Taizhou, China
Notable investors
Matrix Partners China, Shenzhen Ruixiangyuan Fund Management

Frequently asked about Qyuns Therapeutics funding

How much has Qyuns Therapeutics raised?
Qyuns Therapeutics has raised $66M in total disclosed funding across the rounds on record.
Who has invested in Qyuns Therapeutics?
Matrix Partners China, Shenzhen Ruixiangyuan Fund Management are named among the investors backing Qyuns Therapeutics.
What was the latest Qyuns Therapeutics funding round?
The most recent disclosed round is a Series C, announced in April 2021.
Where is Qyuns Therapeutics based?
Qyuns Therapeutics is based in Taizhou, China.
When did Qyuns Therapeutics last raise?
The last disclosed Qyuns Therapeutics round closed in April 2021 at Series C.

Every Qyuns Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Taizhou at a similar stage.

Companies related to Qyuns Therapeutics (23)

Browse related funding lists (4)

Company funding database · Investor directory · Founder database · Mega-rounds 2026